KIORA PHARMACEUTICALS, INC. Operating Lease, Liability, Noncurrent
KIORA PHARMACEUTICALS, INC. (KPRX) had Operating Lease, Liability, Noncurrent of $160.60 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-07
- 2026-06-30: Operating Lease, Liability, Noncurrent $160.60K.
- 2026-03-31: Operating Lease, Liability, Noncurrent $195.37K.
- 2025-12-31: Operating Lease, Liability, Noncurrent $203.80K.
- 2025-09-30: Operating Lease, Liability, Noncurrent $248.24K.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $160.60K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $195.37K 10-Q · filed 2026-05-08 |
| 2025-12-31 | $203.80K 10-Q · filed 2026-08-07 |
| 2025-09-30 | $248.24K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $287.08K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $87.47K 10-Q · filed 2025-05-09 |
| 2024-12-31 | $33.81K 10-K · filed 2026-03-25 |
| 2024-09-30 | $39.19K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $40.20K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $46.45K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $59.82K 10-K · filed 2025-03-25 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-08 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-25 |
| 2022-09-30 | $4.76K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $28.14K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $65.99K 10-Q · filed 2022-07-08 |
| 2021-12-31 | $90.57K 10-K · filed 2023-03-23 |
| 2021-09-30 | $114.47K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $137.96K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $159.94K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $35.63K 10-K/A · filed 2022-07-07 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |